*In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
Both medications belong to the class of glucagon-like peptide 1 (GLP-1) agonists, which are approved for the treatment of type 2 diabetes
A keto plate centers on meat, fish, eggs, or dairy, all of which are dense protein sources
Wegovy has also been shown in studies to be more effective for weight loss
Thats not safe, its not sustainable, and its not what the research shows